- Home
- SRTS
as 07-26-2024 4:00pm EST
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | BOCA RATON |
| Market Cap: | 104.1M | IPO Year: | 2016 |
| Target Price: | $10.00 | AVG Volume (30 days): | 160.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.29 | EPS Growth: | -23.68 |
| 52 Week Low/High: | $1.79 - $6.68 | Next Earning Date: | 08-08-2024 |
| Revenue: | $31,655,000 | Revenue Growth: | -15.83% |
| Revenue Growth (this year): | 44.29% | Revenue Growth (next year): | 19.05% |
Stock Insider Trading Activity of Sensus Healthcare Inc. (SRTS)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Heinrich John | SRTS | Director | May 17 '24 | Sell | $5.95 | 4,773 | $28,399.35 | 75,167 | SEC Form 4 |
| Heinrich John | SRTS | Director | May 17 '24 | Sell | $6.24 | 15,227 | $95,016.48 | 59,940 | SEC Form 4 |
Latest Sensus Healthcare Inc. News
SRTS Breaking Stock News: Dive into SRTS Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Sensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024
Zacks
a day ago
Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?
Zacks
a day ago
Recent Price Trend in Sensus Healthcare (SRTS) is Your Friend, Here's Why
Zacks
3 days ago
Sensus Healthcare, Inc. (SRTS) Dips More Than Broader Market: What You Should Know
Zacks
3 days ago
3 Stocks in Focus as New Analysts Initiate Coverage
Zacks
7 days ago
Sensus Healthcare (SRTS) Upgraded to Buy: What Does It Mean for the Stock?
Zacks
7 days ago
Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?
Zacks
10 days ago
Sensus Healthcare, Inc. (SRTS) Stock Declines While Market Improves: Some Information for Investors
Compare SRTS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SRTS Sensus Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.